Structure and function of S-adenosylhomocysteine hydrolase

Cell Biochemistry and Biophysics

Volumn 33, Issue 2, 2000, Pages 101-125

  Turner, Mary A ^a   Yang, Xiaoda ^b   Yin, Dan ^b   Kuczera, Krzysztof ^b   Borchardt, Ronald T ^b   Howell, P Lynne ^a,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF KANSAS   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adenosine (Ado); Ado kinase(AK); Homocysteine (Hcy); Neplanocin A (Nep A); S adenosylhomocysteine (AdoHcy); S adenosylhomocysteine hydrolase (AdoHcyase); Transmethylations

Indexed keywords

ADENOSYLHOMOCYSTEINASE; ANTIPARASITIC AGENT; ANTIVIRUS AGENT; ENZYME INHIBITOR; HYDROLASE;

AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DRUG EFFECT; HUMAN; MAMMAL; METABOLISM; MOLECULAR GENETICS; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; REVIEW; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

ADENOSYLHOMOCYSTEINASE; AMINO ACID SEQUENCE; ANIMALS; ANTIPARASITIC AGENTS; ANTIVIRAL AGENTS; ENZYME INHIBITORS; HUMANS; HYDROLASES; MAMMALS; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0034570259     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1385/CBB:33:2:101     Document Type: Article

References (107)

1. de la Haba, G. and Cantoni, G. (1959) The enzymatic synthesis of S-adenosyl-L-homocysteine from adenosine and homocysteine. J. Biol. Chem. 234, 603-608.
2. Keller, B. T. and Borchardt, R. T. (1988) in Antiviral Drug Development - A Multidisciplinary Approach (De Clercq, E. and Walker, R. T., eds.), Plenum, New York, pp 123-138.
3. Cantoni, G. L. (1975) Biological Methylation: selected aspects. Annu. Rev. Biochem. 44, 435-151.
4. Cantoni, G. L. and Chiang, P. K. (1980) in Natural Sulfur Compounds (Cavallini, D. and Gaull, G. E., eds.), Plenum, New York, pp 67-80.
5. Chiang, P. K. and Cantoni, G. L. (1979) Perturbation of biochemical transmethylations by 3-deazaadenosine in vivo. Biochem. Pharmacol. 28, 1897-1902.
6. Liu, S., Wolfe, M. S. and Borchardt, R. T. (1992) Rational approaches to the design of antiviral agents based on S-adenosyl-L-homocysteine hydrolase as a molecular target. Antiviral Res. 19, 247-265.
7. Hershfield, M. S. and Kredich, N. M. (1978) S-adenosylhomocysteine hydrolase is an adenosine-binding protein: a target for adenosine toxicity. Science 202, 757-760.
8. Hershfield, M. S. (1979) Apparent suicide inactivation of human lymphoblast S-adenosylho-mocysteine hydrolase by 2′-deoxyadenosine and adenine arabinoside: A basis for direct toxic effects of analogs of adenosine. J. Biol. Chem. 254, 22-25.
9. Kredich, N. M. and Martin, D. W., Jr. (1977) Role of S-adenosylhomocysteine in adenosine mediated toxicity in cultured mouse T lymphoma cells. Cell 12, 931-938.
10. Hershfield, M. S., Kredich, N. M., Ownby, D. R., Ownby, H., and Buckley, R. (1979) In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2′-deoxyadenosine in adenosine deaminase-deficient patients. J. Clin. Invest. 63, 807-811.
11. Robinson, K., Mayer, E., and Jacobsen, D. W. (1994) Homocysteine and coronary artery disease. Clev. Clin. J. Med. 61, 438-450.
12. McKeever, M. P., Weir, D. G., Molloy, A., and Scott, J. M. (1991) Betaine: homocysteine methyltransferase: organ distribution in man, pig and rat and subcellular distribution in the rat. Clin. Sci. 81, 551-556.
13. Graham, I., Daly, L., Refsum, H., Robinson, K., Brattstrom, L., Ueland, P., Palma-Reis, R., Boers, G., Sheahan, R., Israelsson, B., et al. (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277, 1775-1781.
14. Refsum, H., Ueland, P., Nygard, O., and Vollset, S. (1998) Homocysteine and cardiovascular disease. Annu. Rev. Med. 49, 31-62.
15. Majors, A., Ehrhart, L., and Pezacka, E. (1997) Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 17, 2074-2081.
16. Perna, A. G., Ingrosso, D., De Santo, N. G., Galletti, P., Brunone, M., and Zappia, V. (1997) Metabolic consequences of folate-induced reduction of hyperhomocysteinemia in uremia. J. Am. Soc. Nephrol. 8, 1899-1905.
17. Smolin, L. and Benevenga, N. (1982) Accumulation of homocysteine in vitamin B-6 deficiency: a model for the study of cystathionine beta-synthase deficiency. J. Nutr. 112, 1264-1272.
18. Mudd, S. (1985) Vascular disease and homocysteine metabolism. N. Engl. J. Med. 313, 751-753.
19. Brouwer, I., van Dusseldorp, M., Thomas, C., Duran, M., Hautvast J. G., Eskes, T. K. and Steegers-Theunissen, R. P. (1999) Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial. Am. J. Clin. Nutr. 69, 99-104.
20. Henderson, D. M., Hanson, S., Allen, T., Wilson, K., Coulter-Karis, D. E., Greenberg, M. L., Hershfield, M. S. and Ullman, B. (1992) Cloning of the gene encoding Leishmania donovani S-adenosylhomocysteine hydrolase, a potential target for antiparasitic chemotherapy. Mol. Biochem. Parasitol. 53, 169-183.
21. Fujioka, M. and Takata, Y. (1981) S-adenosyl-homocysteine hydrolase from rat liver: purification and some properties. J. Biol. Chem. 256, 1631-1635.
22. Palmer, J. L. and Abeles, R. H. (1979) The mechanism of action of S-adenosylhomocysteinase. J. Biol. Chem. 254, 1217-1226.
23. Bethin, K. E., Petrovic, N., and Ettinger, M. J. (1995) Identification of a Major Hepatic Copper Binding Protein as S-Adenosylhomocysteine Hydrolase. J. Biol. Chem. 270, 20,698-20,702.
24. + transport. J. Biol. Chem. 274, 3842-3850.
25. De Clercq, E., Deschamps, J., De Somer, P., and Holy, A. (1978) (S)-9-(2,3-Dihydroxypropyl)adenine: an aliphatic nucleoside analog with broad-spectrum antiviral activity. Science 200, 563.
26. Banerjee, A. K. (1980) 5′-terminal cap structure in eukaryotic messenger ribonucleic acids. Microbiol. Rev. 44, 175-205.
27. Green, M. R., Manicetis, T., and Metton, D. A. (1983) Human beta-globin pre-mRNA synthesized in vitro is accurately spliced in Xenopus oocyte nuclei. Cell 32, 681-694.
28. Konarska, M. M., Padgett, R. A. and Sharp, P. A. (1984) Recognition of cap structure in splicing in vitro of mRNA precursors. Cell 38, 731-736.
29. Ransohoff, R. M., Narayan, P., Ayers, D. F., Rottman, F. M. and Nilsen, T. W. (1987) Priming of influenza mRNA transcription is inhibited in CHO cells treated with the methylation inhibitor neplanocin A. Antiviral Res. 7, 317-327.
30. Yuan, C.-S., Liu, S., Wnuk, S. F., Robins, M. J., Borchardt, R. T. (1996) Design and synthesis of S-adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents. Adv. Antiviral Drug Design 2, 41-88.
31. Wolfe, M. S. and Borchardt, R. T. (1991) S-adenosyl-L-homocysteine hydrolase as a target for antiviral chemotherapy. J. Med. Chem. 34, 1521-1530.
32. De Clercq, E. (1987) S-Adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents. Biochem. Pharmacol. 36, 2567-2575.
33. Borchardt, R. T., Keller, B. T. and Patel-Thombre, U. (1984) Neplanocin A. A potent inhibitor of S-adenosylhomocysteine hydrolase and of vaccinia virus multiplication in mouse L929 cells. J. Biol. Chem. 259, 4353-4358.
34. Ramakrishnan, V. and Borchardt, R. T. (1987) Adenosine dialdehyde and neplanocin A: Potent inhibitors of S-adenosylhomocysteine hydrolase in neuroblastoma N2a cells. Neurochem. Int. 10, 423-431.
35. Keller, B. T. and Borchardt, R. T. (1987) Adenosine dialdehyde: a potent inhibitor of vaccinia virus multiplication in mouse L929 cells. Mol. Pharmacol. 31, 485-492.
36. Keller, B. T. and Borchardt, R. T. (1986) in Biological Methylation and Drug Design (Borchardt, R. T., Creveling, C. R. and Ueland, P. M., eds.), Humana, Clifton, NJ, pp. 385-396.
37. Bartel, R. L. and Borchardt, R. T. (1984) Effects of adenosine dialdehyde on S-adenosylhomocysteine hydrolase and S-adenosylmethionine-dependent transmethylations in mouse L929 cells. Mol. Pharmacol. 25, 418-424.
38. Hasobe, M., McKee, J. G. and Borchardt, R. T. (1989) Relationship between intracellular concentration of S-adenosylhomocysteine and inhibition of vaccinia virus replication and inhibition of murine L-929 cell growth. Antimicrob. Agents Chemother. 33, 828-834.
39. De Clercq, E. and Holy, A. (1979) Antiviral activity of aliphatic nucleoside analogues: structure-function relationship. J. Med. Chem. 22, 510-513.
40. De Clercq, E. and Holy, A. (1985) Alkyl esters of 3-adenin-9-yl-2-hydroxypropanoic acid: a new class of broad-spectrum antiviral agents. J. Med. Chem. 28, 282-287.
41. Grant, J. and Lerner, L. M. (1979) Dialdehydes derived from adenine nucleosides as substrates and inhibitors of adenosine aminohydrolase. Biochemistry 18, 2838-2842.
42. Chiang, P. K., Cantoni, G. L., Bader, J. P., Shannon, W. M., Thomas, H. J. and Montgomery, J. A. (1978) Adenosylhomocysteine hydrolase inhibitors: synthesis of 5′-deoxy-5′-(isobutylthio)-3-deazaadenosine and its effect on Rous sarcoma virus and Gross murine leukemia virus. Biochem. Biophys. Res. Commun. 82, 417-423.
43. Bader, J. P., Brown, N. R., Chiang, P. K. and Cantoni, G. L. (1978) 3-Deazaadenosine, an inhibitor of adenosylhomocysteine hydrolase, inhibits reproduction of Rous sarcoma virus and transformation of chick embryo cells. Virology 89, 494-505.
44. Bodner, A. J., Cantoni, G. L. and Chiang, P. K. (1981) Anti-viral activity of 3-deazaadenosine and 5′-deoxy-5′-isobutylthio-3-deazaadenosine (3-deaza-SIBA). Biochem. Biophys. Res. Commun. 98, 476-481.
45. Kim, I. K., Zhang, C. Y., Chiang, P. K. and Cantoni, G. L. (1983) S-adenosylhomocysteine hydrolase from hamster liver: purification and kinetic properties. Arch. Biochem. Biophys. 226, 65-72.
46. Guranowski, A., Montgomery, J. A., Cantoni, G. L. and Chiang, P. K. (1981) Adenosine analogues as substrates and inhibitors of S-adenosylhomocysteine hydrolase. Biochemistry 20, 110-115.
47. Cools, M., and De Clercq, E. (1989) Correlation between the antiviral activity of acyclic and carbocyclic adenosine analogues in murine L929 cells and their inhibitory effect on L929 S-adenosylhomocysteine hydrolase. Biochem. Pharmacol. 38, 1061-1067.
48. Matuszewska, B., and Borchardt, R. T. (1987) The role of nicotinamide adenine dinucleotide in the inhibition of bovine liver S-adenosylhomocysteine hydrolase by neplanocin A. J. Biol. Chem. 262, 265-268.
49. Paisley, S. D., Wolfe, M. S. and Borchardt, R. T. (1989) Oxidation of neplanocin A to the corresponding 3′-keto derivative by S-adenosylhomocysteine hydrolase. J. Med. Chem. 32, 1415-1418.
50. Snoeck, R., Andrei, G., Neyts, J., Schols, D., Cools, M., Balzarini, J., and De Clercq, E. (1993) Inhibitory activity of S-adenosylhomocysteine hydrolase inhibitors against human cytomegalovirus replication. Antiviral. Res. 21, 197-216.
51. Huggins, J., Zhang, Z., and Bray, M. (1999) Antiviral drug therapy of filovirus infections: S-adenosyhomocysteine hydrolase inhibitors inhibit ebola virus in vitro and in a lethal mouse model. J. Infect. Dis. 179, S240-247.
52. de Clercq, E., Cools, M., Balzarini, J., Marquez, V. E., Borcherding, D. R., Borchardt, R. T., et al. (1989) Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5′-nor derivatives. Antimicrob. Agents Chemother. 33, 1291-1297.
53. Saunders, P. P., Tan, M. -T., and Robins, R. K. (1985) Metabolism and action of neplanocin A in Chinese hamster ovary cells. Biochem. Pharmacol. 34, 2749-2754.
54. Glazer, R. I. and Knode, M. C. (1984) Neplanocin A. A cyclopentenyl analog of adenosine with specificity for inhibiting RNA methylation. J. Biol. Chem. 259, 12,964-12,969.
55. Keller, B. T. and Borchardt, R. T. (1984) Metabolic conversion of neplanocin A to S-neplanocylmethionine by mouse L929 cells. Biochem. Biophys. Res. Commun. 120, 131-137.
56. Keller, B. T., Clarke, R. S., Pegg, A. E. and Borchardt, R. T. (1985) Purification and characterization of some metabolic effects of S-neplanocylmethionine. Mol. Pharmacol. 28, 364-370.
57. Inaba, M., Nagashima, K., Tsukagoshi, S., and Sakurai, Y. (1986) Biochemical mode of cytotoxic action of neplanocin A in L1210 leukemic cells. Cancer Res. 46, 1063-1067.
58. Bennett, L. L., Allan, P. W. and Hill, D. L. (1968) Metabolic studies with carbocyclic analogs of purine nucleosides. Mol. Pharmacol. 4, 208-217.
59. Ault-Riche, D. B., Lee, Y., Yuan, C. S., Hasobe, M., Wolfe, M. S., Borcherding, D. R. and Borchardt, R. T. (1993) Effects of 4′-modified analogs of aristeromycin on the metabolism of S-adenosyl-L-homocysteine in murine L929 cells. Mol. Pharm. 43, 989-997.
60. Hill, D. L., Straight, S., Allan, P. W. and Bennett, L. L. (1971) Inhibition of guanine metabolism of mammalian tumor cells by the carbocyclic analogue of adenosine. Mol. Pharmacol. 7, 375-380.
61. Bennett, L. L. (1985) Inhibition of utilization of hypoxanthine and guanine in cells treated with the carbocyclic analog of adenosine. Phosphates of carbocyclic nucleoside analogs as inhibitors of hypoxanthine (guanine) phosphoribosyltransferase. Mol. Pharmacol. 27, 666-675.
62. Bloch, A., Robins, M. J. and McCarthy, J. R. J. (1967) The role of the 5′-hydroxyl group of adenosine in determining substrate specificity for adenosine deaminase. J. Med. Chem. 10, 908-912.
63. Glazer, R. I., Knode, M. C., Tseng, C. K., Haines, D. R. and Marquez, V. E. (1986) 3-Deazaneplanocin A: a new inhibitor of S-adenosylhomocysteine synthesis and its effects in human colon carcinoma cells. Biochem. Pharmacol. 35, 4523-4527.
64. Tseng, C. K., Marquez, V. E., Fuller, R. W., Goldstein, B. M., Haines, D. R., McPherson, H, et al. (1989) Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities. J. Med. Chem. 32, 1442-1446.
65. Montgomery, J. A., Clayton, S. J., Thomas, H. J., Shannon, W. M., Arnett, G., Bodner, A. J., et al. (1982) Carbocyclic analogue of 3-deazaadenosine: a novel antiviral agent using S-adenosylhomocysteine hydrolase as a pharmacological target. J. Med. Chem. 25, 626-629.
66. Hasobe, M., McKee, J. G., Borcherding, D. R. and Borchardt, R. T. (1987) 9-(trans-2′, trans-3′-dihydroxycyclopent-4′-enyl)-adenine and -3-deazaadenine: analogs of neplanocin A which retain potent antiviral activity but exhibit reduced cytotoxicity. Antimicrob. Agents Chemother. 31, 1849-1851.
67. Hasobe, M., McKee, J. G., Borcherding, D. R., Keller, B. T. and Borchardt, R. T. (1988) Effects of 9-(trans-2′, trans-3′-dihydroxycyclopent-4′-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 Cells. Mol. Pharmacol. 33, 713-720.
68. Narayanan, S. R., Keller, B. T., Borcherding, D. R., Scholtz, S. A. and Borchardt, R. T. (1988) 9-(trans-2′, trans-3′-dihydroxycyclopent-4′-enyl) derivatives of adenine and 3-deazaadenine: potent inhibitors of bovine liver S-adenosylhomocysteine hyrolase. J. Med. Chem. 31, 500-503.
69. Perry, K. L., Watkins, K. P. and Agabian, N. (1987) Trypanosome mRNAs have unusual "cap 4" structures acquired by addition of a spliced leader. Proc. Natl. Acad. Sci. 84, 8190-8194.
70. Sutton, R. and Boothroyd, J. (1988) The cap of both Miniexon-derived RNA and mRNA of Trypanosomes is 7-Methylguanosine. Mol. Cell. Biol. 8, 494-496.
71. Freistadt, M., Cross, G., and Robertson, H. (1988) Discontinuously synthesized mRNA from Trypanosoma brucei contains the highly methylated 5′-cap structure, m7GpppA (A*C(2′O)mU*A.J. Biol. Chem. 263, 15071-15075.
72. Murphy, W. J., Watkins, K. P. and Agabian, N. (1986) Identification of a novel Y branch structure as an intermediate in Trypanosome mRNA processing: evidence for trans splicing. Cell 47, 517-525.
73. Sutton, R. E. and Boothroyd, J. C. (1986) Evidence for trans splicing in trypanosomes. Cell 47, 527-535.
74. Ullu, E. and Tschudi, C. (1991) Trans splicing in trypanosomes requires methylation of the 5′ end of the spliced leader RNA. Proc. Natl. Acad. Sci. 35, 10074-10078.
75. Bitonti, A. J., Baumann, R. J., Jarvi, E. T., McCarthy, J. R. and McCann, P. P. (1990) Antimalarial activity of a 4′,5′-unsaturated 5′-fluoroadenosine mechanism-based inhibitor of S-adenosyl-L-homocysteine hydrolase. Biochem. Pharmacol. 40, 601-606.
76. Avila, J. L., Avila, A., Polegre, M. A. and Marquez, V. E. (1997) Specific inhibitory effect of 3-deazaneplanocin A against several Leishmania mexicana and L. braziliensis strains. Am. J. Trop. Med. Hyg. 57, 407-412.
77. Yuan, C. S., Yeh, J., Liu, S., and Borchardt, R. T. (1993) Mechanism of inactivation of S-adenosylhomocysteine hydrolase by (Z)-4′,5′-didehydro-5′-fluoroadenosine. J. Biol. Chem. 268, 17030-17037.
78. Turner, M. A., Dole, K., Yuan, C. -S., Hershfield, M. S., Borchardt, R. T. and Howell, P. L. (1997) Crystallization and preliminary X-ray analysis of human placental S-adenosylhomocysteine hydrolase. Acta Cryst. D53, 339-341.
79. Turner, M. A., Yuan, C. -S., Borchardt, R. T., Hershfield, M. S., Smith, G. D. and Howell, P. L. (1998) Structure determination of selenomethionyl S-adenosylhomocysteine hydrolase using data at a single wavelength. Nat. Struct. Biol. 5, 369-376.
80. Smith, G. D., Nagar, B., Rini, J. M., Hauptman, H. A. and Blessing, R. H. (1998) The use of SnB to determine an anomalous scattering substructure. Acta Cryst. D54, 799-804.
81. Weeks, C. M. and Miller, R. (1999) The design and implementation of SnB v2.0. J. Appl. Cryst. 32, 120-124.
82. Ramakrishnan, V. and Biou, V. (1997) Treatment of multiwavelength anomalous diffraction data as a special case of multiple isomorphous replacement. Methods Enzymol. 276, 538-557.
83. Kleijwegt, G. J. and Jones, T. A. (1997) Detecting folding motifs and similarities in protein structures. Methods Enzymol. 277, 525-545.
84. Lamzin, V. S., Aleshin, A. E., Strokopytov, B. V., Yukhnevich, M. G., Popov, V. O., Harutyunyan, E. H. and Wilson, K. S. (1992) Crystal structure of NAD-dependent formate dehydrogenase. Eur. J. Biochem. 206, 441-452.
85. Lesk, A. M. (1995) NAD-binding domains of dehydrogenases. Curr. Op. Struct. Biol. 5, 775-783.
86. Buehner, M., Ford, G. C., Moras, D., Olsen, K. W. and Rossmann, M. G. (1973) D-Glyceraldehyde-3-phosphate dehydrogenase: three-dimensional structure and evolutionary significance. Proc. Natl. Acad. Sci. 70, 3052-3054.
87. Richardson, J. S. (1981) The anatomy and taxonomy of protein structure. Advances in Protein Chemistry 34, 167-339.
88. Degano, M., Gopaul, D. N., Scapin, G., Schramm, V. L. and Sacchettini, J. C. (1996) Three-dimensional structure of the inosine-uridine nucleoside N-ribohydrolase from Crithidia fasciculata. Biochemistry 35, 5971-5981.
89. Degano, M., Almo, S. C., Sacchettini, J. C. and Schramm, V. L. (1998) Trypanosomal Nucleoside Hydrolase. A Novel Mechanism from the Structure with a Transition-State Inhibitor. Biochemistry 37, 6277-6285.
90. Abeles, R. H., Fish, S., and Lapinskas, B. (1982) S-Adenosylhomocysteinase: Mechanism of inactivation by 2′-deoxyadenosine and interaction with other nucleosides. Biochemistry 21, 5557-5562.
91. Cornell, K. A. and Riscoe, M. K. (1998) Cloning and expression of Escherichin coli 5′-methylthioadenosine/S-adenosylhomocysteine nucleosidase: Identification of the pfs gene product. Biochim. Biophys. Acta. 1396, 8-14.
92. Allart, B., Gatel, M., Guillerm, D., and Guillerm, G. (1998) The catalytic mechanism of adenosylhomocysteine/methylthioadenosine nucleosidase from Escherichia coli. Eur. J. Biochem. 256, 155-162.
93. Ault-Riche, D. B., Yuan, C. S. and Borchardt, R. T. (1994) A single mutation at lysine 426 of human placental S-adenosylhomocysteine hydrolase inactivates the enzyme. J. Biol. Chem. 269, 31,472-31,478.
94. Porcelli, M., Cacciapuoti, G., Fusco, S., Iacomino, G., Gambacorta, A., De Rosa, M., and Zappia, V. (1993) S-adenosylhomocysteine hydrolase from the thermophilic archaeon Sulfolobus solfataricus: purification, physicochemical and immunological properties. Biochim. Biophys. Acta 1164, 179-188.
95. Porcelli, M., Cacciapuoti, G., Fusco, S., Bertoldo, C., De Rosa, M., and Zappia, V. (1996) Cloning and sequencing of the gene coding for S-adenosylhomocysteine hydrolase in the thermophilic archaeon Sulfolobus solfataricus. Gene 177, 17-22.
96. Porter, D. J. T. and Boyd, F. L. (1991) Mechanism of bovine liver S-adenosylhomocysteine hydrolase: Steady-state and presteady-state kinetic analysis. J. Biol. Chem. 266, 21,616-21,625.
97. Porter, D. J. T. and Boyd, F. L. (1992) Reduced S-adenosylhomocysteine hydrolase: Kinetics and thermodynamics for binding of 3′-ketoadenosine, adenosine, and adenine. J. Biol. Chem. 267, 3205-3213.
98. Yuan, C. -S., Yeh, J., Squier, T. C., Rawitch, A., and Borchardt, R. T. (1993) Ligand-dependent changes in intrinsic fluorescence of S-adenosylhomocysteine hydrolase: implications for the mechanism of inhibitor-induced inhibition. Biochemistry 32, 10414-10422.
99. Hu, Y., Komoto, J., Huang, Y., Gomi, T., Ogawa, H., Takata, Y., Fujioka, M., and Takusagawa, F. (1999) Crystal structure of S-adenosylhomocysteine hydrolase from rat liver. Biochemistry 38, 8323-8333.
100. Merta, A., Aksamit, R. R., Kasir, J., and Cantoni, G. L. (1995) The gene and pseudogenes of rat S-adenosyl-L-homocysteine hydrolase. Eur. J. Biochem. 229, 575-582.
101. Coulter-Karis, D. E. and Hershfield, M. S. (1989) Sequence of full-length cDNA for human S-adenosylhomocysteine hydrolase. Ann. Hum. Gen. 53, 169-175.
102. De Clercq, E., and Cools, M. (1985) Antiviral potency of adenosine analogues: correlation with inhibition of S-adenosylhomocysteine hydrolase. Biochem. Biophys. Res. Commun. 129, 306-311.
103. Patel-Thombre, U., and Borchardt, R. T. (1985) Adenine nucleoside dialdehydes: potent inhibitors of bovine liver S-adenosylhomocysteine hydrolase. Biochemistry 24, 1130-1136.
104. Houston, D. M., Dolence, E. K., Keller, B. T., Patel-Thombre, U., and Borchardt, R. T. (1985) Potential inhibitors of S-adenosylmethionine-dependent methyltransferases, 9.2′,3′-dialdehyde derivatives of carbocyclic purine nucleosides as inhibitors of S-adenosylhomocysteine hydrolase. J. Med. Chem. 28, 471-477.
105. Wolfe, M. S., Lee, Y., Bartlett, W. J., Borcherding, D. R. and Borchardt, R. T. (1992) 4′-modified analogues of aristeromycin and neplanocin A: synthesis and inhibitory activity toward S-adenosyl-L-homocysteine hydrolase. J. Med. Chem. 35, 1782-1791.
106. Thompson, J. D., Higgins, D. G. and Gibson, T. J. (1994) Clustal W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucl. Acids Res. 22, 4673-4680.
107. Yin, D., Yang, X., Hu, Y., Kucera, K., Schowen, R. L., Borchardt, R. T. and Squier, T. C. (2000) Substrate binding stabilizes S-Adenosylhomocysteine hydrolase in a closed conformation. Biochemistry 39, 9811-9818.